We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Bevacizumab and Lomustine for Recurrent GBM

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01290939
Recruitment Status : Active, not recruiting
First Posted : February 7, 2011
Last Update Posted : July 27, 2017
Information provided by (Responsible Party):